期刊
RADIATION ONCOLOGY
卷 11, 期 -, 页码 -出版社
BIOMED CENTRAL LTD
DOI: 10.1186/s13014-016-0590-1
关键词
Breast cancer radiotherapy; Sequential boost (SEQ); Simultaneous integrated boost (SIB); Biologically effective dose (BED); Biologically effective dose volume histogram (BEDVH)
资金
- Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research, BMBF) [01EZ1130]
- Bundesamt fur Strahlenschutz (Federal Office for Radiation Protection) [BfS 3608S04001]
- Deutscher Akademischer Austausch-Dienst (DAAD - German Academic exchange service)
- Deutsche Forschungsgemeinschaft
- Ruprecht-Karls-Universitat Heidelberg
Purpose: A method is presented to radiobiologically compare sequential (SEQ) and simultaneously integrated boost (SIB) breast radiotherapy. Methods: The method is based on identically prescribed biologically effective dose (iso-BED) which was achieved by different prescribed doses due to different fractionation schemes. It is performed by converting the calculated three-dimensional dose distribution to the corresponding BED distribution taking into consideration the different number of fractions for generic alpha/beta ratios. A cumulative BED volume histogram (BEDVH) is then derived from the BED distribution and is compared for the two delivery schemes. Ten breast cancer patients (4 right-sided and 6 left-sided) were investigated. Two tangential intensity modulated whole breast beams with two other oblique (with different gantry angles) beams for the boost volume were used. The boost and the breast target volumes with either alpha/beta = 10 or 3 Gy, and ipsi-lateral and contra-lateral lungs, heart, and contra-lateral breast as organs at risk (OARs) with alpha/beta = 3 Gy were compared. Results: Based on the BEDVH comparisons, the use of SIB reduced the biological breast mean dose by about 3 %, the ipsi-lateral lung and heart by about 10 %, and contra-lateral breast and lung by about 7 %. Conclusion: BED based comparisons should always be used in comparing plans that have different fraction sizes. SIB schemes are dosimetrically more advantageous than SEQ in breast target volume and OARs for equal prescribed BEDs for breast and boost.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据